Description: Shanghai Yizhong Pharmaceutical Co., Ltd. engages in the development of anti-tumor drugs and related products in China. It develops a dosage form of paclitaxel, an anti-tumor chemotherapeutic. Shanghai Yizhong Pharmaceutical Co., Ltd. was founded in 2009 and is based in Shanghai, China.
Home Page: www.yizhongpharma.com
No.79 Renqi Road
Shanghai,
201403
China
Phone:
86 21 3719 0005
Officers
| Name | Title |
|---|---|
| Mr. Jingsong Zhou | Chairman & GM |
| Mr. Duan Li | Deputy GM & Director |
| Ms. Jing Sun | Deputy GM & Director |
| Zhou Fang | Board Sec. |
Exchange: SHG
Country: CN
Currency: Renminbi (¥)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 70.1727 |
| Price-to-Book MRQ: | 7.9606 |
| Price-to-Sales TTM: | 57.842 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 122 |